Free Trial

Central Garden & Pet (CENT) Financials

Central Garden & Pet logo
$37.83 -0.70 (-1.82%)
As of 02:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Central Garden & Pet

Annual Income Statements for Central Garden & Pet

This table shows Central Garden & Pet's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/26/2015 9/24/2016 9/30/2017 9/29/2018 9/28/2019 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Net Income / (Loss) Attributable to Common Shareholders
32 45 79 124 93 121 152 152 126 108 163
Consolidated Net Income / (Loss)
33 46 80 124 93 122 153 153 126 109 164
Net Income / (Loss) Continuing Operations
33 46 80 124 93 122 153 153 126 109 164
Total Pre-Tax Income
52 70 126 127 119 154 195 199 162 142 217
Total Operating Income
91 129 156 167 152 198 254 260 211 185 250
Total Gross Profit
488 553 633 675 704 797 971 992 947 944 997
Total Revenue
1,651 1,829 2,054 2,215 2,383 2,696 3,304 3,339 3,310 3,200 3,129
Operating Revenue
1,651 1,829 2,054 2,215 2,383 2,696 3,304 3,339 3,310 3,200 3,129
Total Cost of Revenue
1,163 1,276 1,422 1,540 1,679 1,899 2,333 2,346 2,363 2,257 2,132
Operating Cost of Revenue
1,163 1,276 1,422 1,540 1,679 1,899 2,333 2,346 2,363 2,257 2,132
Total Operating Expenses
397 424 477 508 552 599 716 732 736 758 747
Selling, General & Admin Expense
389 422 477 508 552 599 716 732 736 758 747
Total Other Income / (Expense), net
-40 -60 -30 -40 -33 -44 -60 -61 -48 -43 -33
Interest Expense
40 43 28 39 43 44 59 58 57 58 58
Interest & Investment Income
0.13 0.14 0.15 3.15 9.55 4.03 0.42 0.72 7.36 20 25
Other Income / (Expense), net
0.01 -17 -1.62 -3.86 0.24 -4.25 -1.51 -3.60 1.46 -5.09 -0.48
Income Tax Expense
19 24 47 3.31 27 32 42 46 36 33 53
Net Income / (Loss) Attributable to Noncontrolling Interest
1.04 1.07 0.90 0.53 -0.14 0.84 1.03 0.52 0.45 1.33 1.12
Basic Earnings per Share
$0.66 $0.91 $1.57 $2.39 $1.63 $2.23 $2.81 $2.29 $1.92 $1.64 $2.58
Weighted Average Basic Shares Outstanding
48.56M 48.96M 50.23M 51.72M 56.77M 54.01M 53.91M 66.53M 65.49M 65.71M 63.09M
Diluted Earnings per Share
$0.64 $0.87 $1.52 $2.32 $1.61 $2.20 $2.75 $2.24 $1.88 $1.62 $2.55
Weighted Average Diluted Shares Outstanding
49.64M 51.08M 51.82M 53.34M 57.61M 54.74M 55.25M 68.03M 66.78M 66.86M 63.82M
Weighted Average Basic & Diluted Shares Outstanding
48.40M 48.90M 50.20M 57.81M 55.93M 54.84M 55.15M 54.12M 53.81M 65.59M 62.33M

Quarterly Income Statements for Central Garden & Pet

This table shows Central Garden & Pet's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Net Income / (Loss) Attributable to Common Shareholders
83 2.84 0.43 62 80 -34 14 64 95 -9.81 6.84
Consolidated Net Income / (Loss)
84 2.72 0.57 63 80 -34 14 65 95 -10 6.86
Net Income / (Loss) Continuing Operations
84 2.72 0.57 63 80 -34 14 65 95 -10 6.86
Total Pre-Tax Income
111 -0.38 -0.30 82 106 -45 19 85 127 -14 8.95
Total Operating Income
123 9.37 8.41 93 116 -32 28 93 135 -6.40 17
Total Gross Profit
318 197 179 279 317 169 196 273 332 197 191
Total Revenue
1,023 750 635 900 996 669 656 834 961 678 617
Operating Revenue
1,023 750 635 900 996 669 656 834 961 678 617
Total Cost of Revenue
705 553 456 621 679 501 461 560 629 482 427
Operating Cost of Revenue
705 553 456 621 679 501 461 560 629 482 427
Total Operating Expenses
195 188 170 185 201 201 168 180 197 203 174
Selling, General & Admin Expense
195 188 170 185 201 201 168 180 197 203 174
Total Other Income / (Expense), net
-12 -9.75 -8.71 -12 -9.99 -13 -9.45 -8.61 -7.77 -7.46 -7.59
Interest Expense
15 13 14 14 15 14 14 15 14 14 15
Interest & Investment Income
1.41 5.08 4.61 2.90 4.50 7.64 6.74 5.15 5.52 7.48 6.74
Other Income / (Expense), net
0.85 -1.69 0.99 -0.17 0.23 -6.14 -1.72 0.74 1.07 -0.58 0.18
Income Tax Expense
27 -3.10 -0.87 19 25 -11 4.36 20 32 -3.42 2.09
Net Income / (Loss) Attributable to Noncontrolling Interest
0.42 -0.12 0.14 0.68 0.75 -0.24 0.17 1.17 0.40 -0.63 0.02
Basic Earnings per Share
$1.27 $0.04 $0.01 $0.94 $1.21 ($0.52) $0.22 $0.99 $1.53 ($0.16) $0.11
Weighted Average Basic Shares Outstanding
65.58M 65.49M 65.42M 65.64M 65.85M 65.71M 64.55M 64.14M 61.98M 63.09M 61.41M
Diluted Earnings per Share
$1.25 $0.04 $0.01 $0.93 $1.19 ($0.52) $0.21 $0.98 $1.52 ($0.16) $0.11
Weighted Average Diluted Shares Outstanding
66.73M 66.78M 66.79M 66.83M 66.95M 66.86M 65.45M 64.88M 62.61M 63.82M 62.06M
Weighted Average Basic & Diluted Shares Outstanding
53.68M 53.81M 53.78M 67.40M 67.42M 65.59M 65.51M 63.41M 62.87M 62.33M 62.27M

Annual Cash Flow Statements for Central Garden & Pet

This table details how cash moves in and out of Central Garden & Pet's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/26/2015 9/24/2016 9/30/2017 9/29/2018 9/28/2019 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Net Change in Cash & Equivalents
-31 45 -59 448 18 156 -227 -247 311 266 130
Net Cash From Operating Activities
87 151 114 114 205 264 251 -34 382 395 333
Net Cash From Continuing Operating Activities
87 151 114 114 205 264 251 -34 382 395 333
Net Income / (Loss) Continuing Operations
33 46 80 124 93 122 153 153 126 109 164
Consolidated Net Income / (Loss)
33 46 80 124 93 122 153 153 126 109 164
Depreciation Expense
34 40 43 47 51 55 75 81 88 91 85
Amortization Expense
2.00 1.50 1.36 1.75 1.83 1.87 2.21 2.66 2.70 2.69 2.70
Non-Cash Adjustments To Reconcile Net Income
15 24 -6.82 14 15 63 80 74 90 126 94
Changes in Operating Assets and Liabilities, net
4.13 41 -2.68 -73 45 22 -59 -344 75 66 -13
Net Cash From Investing Activities
-50 -91 -163 -141 -76 -48 -899 -143 -35 -105 -45
Net Cash From Continuing Investing Activities
-50 -91 -163 -141 -76 -48 -899 -143 -35 -105 -45
Purchase of Property, Plant & Equipment
-22 -28 -45 -38 -32 -43 -80 -115 -54 -43 -41
Acquisitions
-38 -69 -122 -100 -43 -4.44 -821 -28 -0.50 -62 -3.32
Divestitures
- - - - 0.00 0.00 2.40 0.00 20 0.00 0.00
Other Investing Activities, net
0.58 1.52 -4.36 -2.75 -1.52 -0.61 -0.47 0.04 -0.12 -0.18 -0.15
Net Cash From Financing Activities
-68 -14 -10 475 -111 -61 420 -67 -38 -25 -157
Net Cash From Continuing Financing Activities
-68 -14 -10 475 -111 -61 420 -67 -38 -25 -157
Repayment of Debt
-363 -827 -552 -28 -48 -201 -1,309 -3.51 -48 -0.37 -0.23
Repurchase of Common Equity
-18 -11 -28 -14 -63 -59 -28 -62 -37 -24 -155
Payment of Dividends
-1.68 -0.59 -1.02 -1.60 -0.08 -0.14 -0.61 -0.81 0.00 -0.90 -1.35
Issuance of Debt
312 819 552 323 0.00 200 1,758 0.00 48 0.00 0.00
Issuance of Common Equity
0.20 0.32 0.00 196 - - - - 0.00 0.00 0.00
Other Financing Activities, net
2.15 4.84 19 -0.25 -0.17 -0.23 -0.37 -0.22 -0.05 -0.10 0.00
Effect of Exchange Rate Changes
-0.32 -0.67 - - -0.25 0.09 1.17 -3.51 1.19 1.26 -0.95
Cash Interest Paid
40 33 28 37 43 44 43 58 57 58 58
Cash Income Taxes Paid
3.19 10 11 20 15 26 71 35 18 54 62

Quarterly Cash Flow Statements for Central Garden & Pet

This table details how cash moves in and out of Central Garden & Pet's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Net Change in Cash & Equivalents
273 156 -147 -40 269 184 -136 -101 196 171 -161
Net Cash From Operating Activities
325 154 -70 -25 286 203 -69 -47 265 183 -70
Net Cash From Continuing Operating Activities
325 153 -70 -25 286 203 -69 -47 265 183 -70
Net Income / (Loss) Continuing Operations
84 2.72 0.57 63 80 -34 14 65 95 -10 6.86
Consolidated Net Income / (Loss)
84 2.72 0.57 63 80 -34 14 65 95 -10 6.86
Depreciation Expense
22 22 23 23 23 23 22 21 21 21 21
Amortization Expense
0.67 0.68 0.67 0.67 0.67 0.67 0.67 0.67 0.67 0.67 0.64
Non-Cash Adjustments To Reconcile Net Income
33 17 18 18 38 52 20 18 20 35 24
Changes in Operating Assets and Liabilities, net
185 111 -112 -129 144 163 -126 -151 128 137 -122
Net Cash From Investing Activities
-11 6.87 -70 -9.81 -14 -11 -9.42 -11 -14 -11 -68
Net Cash From Continuing Investing Activities
-11 6.87 -70 -9.81 -14 -11 -9.42 -11 -14 -11 -68
Purchase of Property, Plant & Equipment
-11 -13 -10 -9.35 -14 -10 -6.10 -11 -14 -11 -11
Acquisitions
- - -60 -0.32 -0.65 -0.56 -3.32 - - - -57
Net Cash From Financing Activities
-42 -3.89 -7.79 -5.39 -2.84 -9.43 -55 -44 -57 -0.36 -23
Net Cash From Continuing Financing Activities
-42 -3.89 -7.79 -5.39 -2.84 -9.43 -55 -44 -57 -0.36 -23
Repayment of Debt
-25 -0.12 -0.09 -0.07 -0.13 -0.08 -0.08 -0.07 -0.06 -0.03 -2.34
Repurchase of Common Equity
-17 -3.75 -6.78 -5.28 -2.70 -9.32 -54 -44 -57 -0.33 -20
Payment of Dividends
- - -0.90 - - 0.00 -1.35 - - - -1.14
Effect of Exchange Rate Changes
0.89 -0.86 0.79 -0.38 -0.12 0.96 -2.04 0.59 1.33 -0.83 0.33
Cash Interest Paid
20 7.72 20 8.94 20 8.68 20 9.07 20 8.92 20

Annual Balance Sheets for Central Garden & Pet

This table presents Central Garden & Pet's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/26/2015 9/24/2016 9/30/2017 9/29/2018 9/28/2019 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Total Assets
1,132 1,181 1,307 1,907 2,025 2,339 3,117 3,282 3,379 3,553 3,626
Total Current Assets
654 683 683 1,217 1,307 1,525 1,544 1,554 1,707 1,887 1,976
Cash & Equivalents
48 93 32 482 498 653 426 177 489 754 882
Restricted Cash
13 11 13 11 13 14 13 15 14 15 16
Accounts Receivable
207 201 238 276 300 392 385 377 333 326 325
Inventories, net
336 362 382 428 466 440 685 938 838 758 722
Prepaid Expenses
50 16 18 21 30 27 34 47 33 34 30
Plant, Property, & Equipment, net
163 158 181 218 245 0.00 329 397 392 379 363
Total Noncurrent Assets
315 339 443 472 472 814 1,244 1,331 1,280 1,287 1,286
Goodwill
209 231 256 281 286 290 369 546 546 551 555
Intangible Assets
75 96 116 152 146 135 134 543 497 473 448
Other Noncurrent Operating Assets
30 12 71 39 40 389 741 242 236 263 284
Total Liabilities & Shareholders' Equity
1,132 1,181 1,307 1,907 2,025 2,339 3,117 3,282 3,379 3,553 3,626
Total Liabilities
625 626 670 954 1,029 1,262 1,893 1,947 1,926 1,996 2,041
Total Current Liabilities
177 202 220 213 279 440 522 466 458 515 539
Short-Term Debt
0.29 0.46 0.38 0.12 0.11 0.10 1.08 0.32 0.25 0.24 0.06
Accounts Payable
89 102 103 110 149 205 246 216 191 213 235
Accrued Expenses
88 99 117 103 129 201 235 202 216 245 247
Other Current Liabilities
- - - - 0.00 33 41 48 51 57 57
Total Noncurrent Liabilities
448 424 450 741 750 821 1,371 1,481 1,468 1,481 1,502
Long-Term Debt
448 424 450 741 693 694 1,185 1,186 1,188 1,190 1,192
Noncurrent Deferred & Payable Income Tax Liabilities
- - - - 57 41 56 147 144 118 119
Other Noncurrent Operating Liabilities
- - - - 0.00 87 130 148 136 173 192
Total Equity & Noncontrolling Interests
506 555 637 953 996 1,078 1,224 1,335 1,453 1,558 1,585
Total Preferred & Common Equity
505 553 636 952 996 1,077 1,222 1,334 1,451 1,556 1,583
Total Common Equity
505 553 635 952 996 1,076 1,222 1,334 1,451 1,556 1,583
Common Stock
389 393 397 590 576 567 577 583 595 599 572
Retained Earnings
116 161 239 363 422 511 646 755 859 960 1,015
Accumulated Other Comprehensive Income / (Loss)
0.16 -1.29 -0.95 -1.22 -1.68 -1.41 -0.83 -4.15 -2.97 -2.63 -3.85
Noncontrolling Interest
1.09 1.57 1.46 0.39 0.17 0.87 1.29 1.01 1.46 1.89 1.67

Quarterly Balance Sheets for Central Garden & Pet

This table presents Central Garden & Pet's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/25/2022 12/24/2022 3/25/2023 6/24/2023 12/30/2023 3/30/2024 6/29/2024 12/28/2024 3/29/2025 6/28/2025 12/27/2025
Total Assets
3,346 3,229 3,351 3,420 3,422 3,540 3,608 3,536 3,630 3,657 3,643
Total Current Assets
1,633 1,513 1,654 1,742 1,714 1,851 1,910 1,888 1,975 2,000 1,966
Cash & Equivalents
196 88 61 333 341 301 570 618 517 713 721
Restricted Cash
13 15 13 14 14 14 14 15 15 15 16
Accounts Receivable
506 329 565 493 371 578 508 399 579 523 358
Inventories, net
883 1,024 967 865 948 914 785 816 824 718 836
Prepaid Expenses
36 57 48 37 39 43 33 40 41 31 34
Plant, Property, & Equipment, net
390 397 396 392 389 387 384 371 368 366 359
Total Noncurrent Assets
1,322 1,320 1,301 1,286 1,319 1,302 1,313 1,277 1,286 1,291 1,319
Goodwill
512 546 546 546 546 546 546 551 555 555 555
Intangible Assets
491 534 525 512 489 481 473 466 462 455 441
Other Noncurrent Operating Assets
319 239 229 227 283 275 294 260 270 281 323
Total Liabilities & Shareholders' Equity
3,346 3,229 3,351 3,420 3,422 3,540 3,608 3,536 3,630 3,657 3,643
Total Liabilities
1,994 1,906 1,979 1,973 1,970 2,028 2,012 2,016 2,086 2,067 2,067
Total Current Liabilities
516 423 476 496 494 556 521 544 598 562 574
Short-Term Debt
0.35 0.30 0.27 0.26 0.47 0.32 0.29 0.17 0.12 0.08 0.06
Accounts Payable
241 194 225 198 212 237 191 222 264 211 264
Accrued Expenses
229 179 201 248 230 268 277 263 275 294 257
Other Current Liabilities
46 49 49 50 51 51 53 59 58 57 53
Total Noncurrent Liabilities
1,477 1,483 1,503 1,476 1,476 1,471 1,491 1,472 1,489 1,505 1,493
Long-Term Debt
1,186 1,187 1,212 1,187 1,189 1,189 1,189 1,190 1,191 1,191 1,192
Noncurrent Deferred & Payable Income Tax Liabilities
136 151 155 157 150 148 150 119 122 125 120
Other Noncurrent Operating Liabilities
155 145 136 132 137 135 151 163 176 188 181
Total Equity & Noncontrolling Interests
1,352 1,323 1,372 1,447 1,453 1,512 1,596 1,520 1,543 1,591 1,576
Total Preferred & Common Equity
1,351 1,323 1,371 1,446 1,452 1,511 1,594 1,519 1,542 1,588 1,575
Total Common Equity
1,351 1,323 1,371 1,446 1,452 1,511 1,594 1,519 1,542 1,588 1,575
Common Stock
582 586 588 589 595 593 596 587 576 567 569
Retained Earnings
771 741 787 858 859 921 1,001 936 970 1,025 1,009
Accumulated Other Comprehensive Income / (Loss)
-1.92 -3.36 -3.60 -1.96 -2.11 -2.83 -3.20 -4.66 -4.62 -3.53 -3.36
Noncontrolling Interest
1.38 0.59 1.15 1.58 0.70 1.38 2.13 0.72 1.89 2.30 0.54

Annual Metrics And Ratios for Central Garden & Pet

This table displays calculated financial ratios and metrics derived from Central Garden & Pet's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/26/2015 9/24/2016 9/30/2017 9/29/2018 9/28/2019 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024 9/27/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.89% 10.80% 12.33% 7.83% 7.57% 13.11% 22.56% 1.06% -0.85% -3.31% -2.23%
EBITDA Growth
34.54% 21.00% 29.07% 6.98% -3.51% 22.44% 31.47% 3.07% -11.04% -9.49% 23.14%
EBIT Growth
61.52% 22.85% 37.51% 5.82% -6.83% 27.19% 30.59% 1.36% -17.29% -15.00% 38.42%
NOPAT Growth
47.08% 44.60% 16.26% 65.56% -27.52% 32.46% 27.54% 0.01% -18.08% -12.98% 32.93%
Net Income Growth
236.17% 38.07% 74.90% 55.68% -25.36% 31.16% 25.72% -0.07% -17.41% -13.31% 49.99%
EPS Growth
255.56% 35.94% 74.71% 52.63% -30.60% 36.65% 25.00% -0.07% -17.41% -13.83% 57.41%
Operating Cash Flow Growth
-30.85% 73.16% -24.51% -0.17% 79.63% 28.93% -5.08% -113.57% 1,221.46% 3.47% -15.80%
Free Cash Flow Firm Growth
-66.96% 178.61% -166.02% 105.39% 3,708.73% 63.11% -389.35% 75.98% 321.93% -15.01% -3.69%
Invested Capital Growth
2.44% -2.15% 19.09% 15.29% -1.89% -6.22% 78.21% 18.24% -8.20% -7.43% -5.10%
Revenue Q/Q Growth
0.74% 1.50% 3.90% 0.54% 1.64% 5.28% 1.95% -0.94% 1.31% -2.46% 0.28%
EBITDA Q/Q Growth
1.11% -1.65% 9.65% 0.87% -0.97% 7.16% -3.24% 1.07% -1.10% -14.30% 9.65%
EBIT Q/Q Growth
-0.14% -4.28% 12.23% 0.46% -2.05% 8.10% -6.44% 1.15% -1.37% -20.41% 14.48%
NOPAT Q/Q Growth
-2.54% 10.94% 0.12% 8.91% -10.83% 9.84% -5.93% 0.32% 0.55% -19.98% 11.92%
Net Income Q/Q Growth
-0.62% -3.18% 13.84% 5.58% -8.33% 10.59% -9.91% 0.56% 4.20% -25.35% 17.12%
EPS Q/Q Growth
-1.54% -2.25% 14.29% 4.04% -6.94% 8.91% -11.86% 0.56% 4.20% -26.36% 14.35%
Operating Cash Flow Q/Q Growth
-23.43% 25.73% 9.40% 27.61% 8.36% 31.42% -29.14% -234.45% 38.31% 14.17% -5.77%
Free Cash Flow Firm Q/Q Growth
-64.68% 285.91% -73.30% 112.51% 76.12% 37.03% -51.37% 31.83% 73.26% 13.70% -8.19%
Invested Capital Q/Q Growth
5.00% -2.89% 0.30% -1.38% -7.25% -11.25% 3.84% -0.04% -6.56% -10.08% -8.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
29.57% 30.24% 30.80% 30.49% 29.54% 29.55% 29.39% 29.72% 28.60% 29.49% 31.87%
EBITDA Margin
7.70% 8.41% 9.67% 9.59% 8.60% 9.31% 9.99% 10.19% 9.14% 8.55% 10.77%
Operating Margin
5.54% 7.07% 7.60% 7.55% 6.38% 7.34% 7.70% 7.79% 6.36% 5.79% 7.99%
EBIT Margin
5.54% 6.14% 7.52% 7.38% 6.39% 7.19% 7.66% 7.68% 6.41% 5.63% 7.98%
Profit (Net Income) Margin
2.00% 2.49% 3.88% 5.60% 3.89% 4.51% 4.62% 4.57% 3.81% 3.42% 5.24%
Tax Burden Percent
64.04% 65.46% 63.06% 97.41% 77.69% 79.04% 78.42% 76.76% 77.62% 76.75% 75.65%
Interest Burden Percent
56.37% 61.99% 81.84% 77.95% 78.29% 79.36% 77.00% 77.56% 76.59% 78.99% 86.85%
Effective Tax Rate
35.96% 34.54% 36.94% 2.59% 22.31% 20.96% 21.58% 23.24% 22.38% 23.25% 24.35%
Return on Invested Capital (ROIC)
6.63% 9.57% 10.27% 14.53% 9.93% 13.70% 12.98% 9.29% 7.32% 6.91% 9.81%
ROIC Less NNEP Spread (ROIC-NNEP)
0.03% -1.47% 5.11% 2.63% -1.90% -19.58% 0.88% 3.89% 2.87% 0.95% 2.76%
Return on Net Nonoperating Assets (RNNOA)
0.02% -0.98% 3.11% 1.08% -0.42% -1.98% 0.30% 2.65% 1.73% 0.35% 0.63%
Return on Equity (ROE)
6.65% 8.59% 13.38% 15.61% 9.51% 11.72% 13.28% 11.94% 9.05% 7.26% 10.44%
Cash Return on Invested Capital (CROIC)
4.22% 11.74% -7.15% 0.33% 11.84% 20.12% -43.24% -7.43% 15.87% 14.63% 15.04%
Operating Return on Assets (OROA)
8.02% 9.72% 12.42% 10.17% 7.75% 8.88% 9.27% 8.02% 6.37% 5.20% 6.95%
Return on Assets (ROA)
2.90% 3.94% 6.41% 7.72% 4.71% 5.57% 5.60% 4.77% 3.79% 3.15% 4.57%
Return on Common Equity (ROCE)
6.63% 8.56% 13.34% 15.58% 9.50% 11.71% 13.26% 11.92% 9.04% 7.25% 10.42%
Return on Equity Simple (ROE_SIMPLE)
6.53% 8.24% 12.54% 13.03% 9.30% 11.29% 12.50% 11.45% 8.69% 7.03% 0.00%
Net Operating Profit after Tax (NOPAT)
59 85 98 163 118 156 200 200 164 142 189
NOPAT Margin
3.55% 4.63% 4.79% 7.36% 4.96% 5.81% 6.04% 5.98% 4.94% 4.45% 6.04%
Net Nonoperating Expense Percent (NNEP)
6.60% 11.04% 5.16% 11.90% 11.83% 33.29% 12.10% 5.39% 4.46% 5.96% 7.05%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 6.81%
Cost of Revenue to Revenue
70.44% 69.76% 69.20% 69.51% 70.46% 70.45% 70.61% 70.28% 71.40% 70.51% 68.13%
SG&A Expenses to Revenue
23.59% 23.07% 23.20% 22.93% 23.16% 22.21% 21.69% 21.93% 22.24% 23.70% 23.88%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.03% 23.17% 23.20% 22.93% 23.16% 22.21% 21.69% 21.93% 22.24% 23.70% 23.88%
Earnings before Interest and Taxes (EBIT)
91 112 154 163 152 194 253 256 212 180 250
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
127 154 199 212 205 251 330 340 303 274 337
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.62 2.34 3.17 1.98 1.72 1.92 2.13 1.53 1.63 1.59 1.32
Price to Tangible Book Value (P/TBV)
3.71 5.73 7.65 3.63 3.03 3.17 3.62 8.39 5.81 4.65 3.60
Price to Revenue (P/Rev)
0.50 0.71 0.98 0.85 0.72 0.77 0.79 0.61 0.72 0.77 0.67
Price to Earnings (P/E)
25.56 29.00 25.51 15.22 18.42 17.13 17.13 13.45 18.86 22.88 12.83
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.91% 3.45% 3.92% 6.57% 5.43% 5.84% 5.84% 7.43% 5.30% 4.37% 7.79%
Enterprise Value to Invested Capital (EV/IC)
1.35 1.84 2.32 1.77 1.61 1.90 1.70 1.31 1.43 1.46 1.27
Enterprise Value to Revenue (EV/Rev)
0.73 0.88 1.18 0.96 0.79 0.78 1.01 0.91 0.92 0.90 0.76
Enterprise Value to EBITDA (EV/EBITDA)
9.49 10.48 12.17 10.03 9.23 8.35 10.15 8.95 10.10 10.57 7.07
Enterprise Value to EBIT (EV/EBIT)
13.19 14.36 15.65 13.03 12.42 10.82 13.23 11.86 14.41 16.05 9.55
Enterprise Value to NOPAT (EV/NOPAT)
20.60 19.05 24.55 13.07 16.01 13.39 16.77 15.24 18.69 20.34 12.60
Enterprise Value to Operating Cash Flow (EV/OCF)
13.79 10.65 21.15 18.67 9.23 7.93 13.34 0.00 8.01 7.33 7.17
Enterprise Value to Free Cash Flow (EV/FCFF)
32.35 15.53 0.00 575.89 13.43 9.12 0.00 0.00 8.62 9.61 8.22
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.89 0.77 0.71 0.78 0.70 0.64 0.97 0.89 0.82 0.76 0.75
Long-Term Debt to Equity
0.89 0.76 0.71 0.78 0.70 0.64 0.97 0.89 0.82 0.76 0.75
Financial Leverage
0.78 0.67 0.61 0.41 0.22 0.10 0.34 0.68 0.60 0.37 0.23
Leverage Ratio
2.30 2.18 2.09 2.02 2.02 2.10 2.37 2.50 2.39 2.30 2.28
Compound Leverage Factor
1.29 1.35 1.71 1.58 1.58 1.67 1.83 1.94 1.83 1.82 1.98
Debt to Total Capital
46.98% 43.35% 41.39% 43.76% 41.03% 39.17% 49.22% 47.06% 44.99% 43.31% 42.92%
Short-Term Debt to Total Capital
0.03% 0.05% 0.03% 0.01% 0.01% 0.01% 0.04% 0.01% 0.01% 0.01% 0.00%
Long-Term Debt to Total Capital
46.94% 43.30% 41.35% 43.76% 41.02% 39.17% 49.17% 47.05% 44.98% 43.30% 42.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.11% 0.16% 0.13% 0.02% 0.01% 0.05% 0.05% 0.04% 0.06% 0.07% 0.06%
Common Equity to Total Capital
52.86% 56.44% 58.43% 56.18% 58.96% 60.75% 50.73% 52.90% 54.95% 56.62% 57.02%
Debt to EBITDA
3.53 2.76 2.27 3.49 3.38 2.77 3.59 3.49 3.93 4.35 3.53
Net Debt to EBITDA
3.05 2.08 2.04 1.17 0.89 0.11 2.26 2.92 2.27 1.54 0.87
Long-Term Debt to EBITDA
3.53 2.76 2.26 3.49 3.38 2.77 3.59 3.49 3.93 4.35 3.53
Debt to NOPAT
7.66 5.01 4.57 4.55 5.87 4.44 5.94 5.94 7.27 8.36 6.30
Net Debt to NOPAT
6.62 3.78 4.11 1.52 1.54 0.18 3.74 4.98 4.19 2.96 1.55
Long-Term Debt to NOPAT
7.66 5.01 4.57 4.55 5.87 4.43 5.94 5.94 7.27 8.36 6.30
Altman Z-Score
3.16 3.78 4.44 3.53 3.32 3.27 2.84 2.63 2.72 2.65 2.57
Noncontrolling Interest Sharing Ratio
0.39% 0.35% 0.34% 0.18% 0.06% 0.08% 0.12% 0.09% 0.09% 0.11% 0.11%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.70 3.38 3.10 5.72 4.69 3.46 2.96 3.34 3.73 3.66 3.67
Quick Ratio
1.44 1.45 1.23 3.56 2.86 2.37 1.55 1.19 1.79 2.10 2.24
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
37 104 -69 3.70 141 230 -665 -160 354 301 290
Operating Cash Flow to CapEx
396.95% 638.63% 316.54% 301.52% 649.12% 613.80% 312.26% -29.54% 707.17% 915.48% 802.81%
Free Cash Flow to Firm to Interest Expense
0.93 2.42 -2.43 0.09 3.31 5.22 -11.35 -2.74 6.22 5.24 5.03
Operating Cash Flow to Interest Expense
2.18 3.53 4.05 2.91 4.81 6.00 4.28 -0.58 6.69 6.86 5.76
Operating Cash Flow Less CapEx to Interest Expense
1.63 2.98 2.77 1.95 4.07 5.03 2.91 -2.56 5.75 6.11 5.05
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.45 1.58 1.65 1.38 1.21 1.24 1.21 1.04 0.99 0.92 0.87
Accounts Receivable Turnover
8.23 8.95 9.36 8.62 8.27 7.79 8.50 8.76 9.33 9.71 9.61
Inventory Turnover
3.51 3.66 3.82 3.80 3.76 4.19 4.15 2.89 2.66 2.83 2.88
Fixed Asset Turnover
10.01 11.39 12.12 11.12 10.29 0.00 0.00 9.20 8.39 8.30 8.43
Accounts Payable Turnover
13.11 13.34 13.82 14.42 12.94 10.71 10.35 10.17 11.62 11.19 9.53
Days Sales Outstanding (DSO)
44.35 40.77 39.00 42.32 44.12 46.85 42.93 41.66 39.13 37.58 38.00
Days Inventory Outstanding (DIO)
103.96 99.83 95.52 95.98 97.18 87.05 88.00 126.26 137.17 129.08 126.71
Days Payable Outstanding (DPO)
27.83 27.36 26.41 25.31 28.21 34.07 35.27 35.88 31.40 32.63 38.29
Cash Conversion Cycle (CCC)
120.48 113.23 108.11 113.00 113.09 99.83 95.67 132.05 144.89 134.03 126.42
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
894 875 1,042 1,201 1,179 1,105 1,970 2,329 2,138 1,979 1,878
Invested Capital Turnover
1.87 2.07 2.14 1.98 2.00 2.36 2.15 1.55 1.48 1.55 1.62
Increase / (Decrease) in Invested Capital
21 -19 167 159 -23 -73 864 359 -191 -159 -101
Enterprise Value (EV)
1,206 1,613 2,417 2,130 1,892 2,096 3,347 3,042 3,056 2,895 2,384
Market Capitalization
817 1,291 2,011 1,881 1,709 2,068 2,600 2,047 2,369 2,471 2,089
Book Value per Share
$10.12 $10.86 $12.27 $18.24 $17.24 $19.68 $21.94 $24.53 $27.04 $23.07 $25.18
Tangible Book Value per Share
$4.42 $4.43 $5.08 $9.93 $9.76 $11.91 $12.90 $4.49 $7.60 $7.88 $9.24
Total Capital
955 979 1,087 1,694 1,689 1,772 2,409 2,521 2,641 2,748 2,777
Total Debt
449 424 450 742 693 694 1,186 1,187 1,188 1,190 1,192
Total Long-Term Debt
448 424 450 741 693 694 1,185 1,186 1,188 1,190 1,192
Net Debt
388 320 405 249 182 28 746 994 685 422 293
Capital Expenditures (CapEx)
22 24 36 38 32 43 80 115 54 43 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
416 378 418 511 518 419 583 896 747 603 539
Debt-free Net Working Capital (DFNWC)
477 482 463 1,004 1,029 1,085 1,022 1,088 1,249 1,372 1,437
Net Working Capital (NWC)
477 481 463 1,004 1,029 1,085 1,021 1,088 1,249 1,371 1,437
Net Nonoperating Expense (NNE)
26 39 19 39 25 35 47 47 37 33 25
Net Nonoperating Obligations (NNO)
388 320 405 249 182 28 746 994 685 422 293
Total Depreciation and Amortization (D&A)
36 42 44 49 53 57 77 84 90 93 88
Debt-free, Cash-free Net Working Capital to Revenue
25.23% 20.65% 20.36% 23.09% 21.74% 15.53% 17.64% 26.84% 22.55% 18.85% 17.23%
Debt-free Net Working Capital to Revenue
28.91% 26.33% 22.55% 45.34% 43.17% 40.26% 30.95% 32.60% 37.74% 42.86% 45.94%
Net Working Capital to Revenue
28.89% 26.30% 22.53% 45.34% 43.17% 40.25% 30.92% 32.59% 37.74% 42.85% 45.94%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.53 $0.73 $1.26 $1.92 $1.31 $1.79 $2.25 $2.29 $1.92 $1.64 $2.58
Adjusted Weighted Average Basic Shares Outstanding
60.59M 61.09M 62.67M 64.52M 70.83M 67.38M 67.26M 66.40M 65.37M 65.71M 63.09M
Adjusted Diluted Earnings per Share
$0.51 $0.70 $1.22 $1.86 $1.29 $1.76 $2.20 $2.24 $1.88 $1.62 $2.55
Adjusted Weighted Average Diluted Shares Outstanding
61.93M 63.72M 64.65M 66.55M 71.88M 68.29M 68.93M 67.90M 66.66M 66.86M 63.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
62.44M 63.77M 64.69M 72.13M 69.78M 68.42M 68.80M 67.52M 67.14M 65.59M 62.33M
Normalized Net Operating Profit after Tax (NOPAT)
63 86 98 163 118 156 200 200 164 142 189
Normalized NOPAT Margin
3.83% 4.70% 4.79% 7.36% 4.96% 5.81% 6.04% 5.98% 4.94% 4.45% 6.04%
Pre Tax Income Margin
3.12% 3.81% 6.15% 5.75% 5.00% 5.70% 5.90% 5.96% 4.91% 4.45% 6.93%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.28 2.62 5.48 4.17 3.57 4.40 4.32 4.40 3.72 3.13 4.33
NOPAT to Interest Expense
1.46 1.98 3.49 4.16 2.77 3.56 3.41 3.43 2.87 2.47 3.28
EBIT Less CapEx to Interest Expense
1.73 2.07 4.20 3.21 2.83 3.42 2.95 2.42 2.77 2.38 3.61
NOPAT Less CapEx to Interest Expense
0.91 1.42 2.21 3.19 2.03 2.58 2.04 1.45 1.92 1.72 2.56
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
5.09% 1.30% 1.28% 1.29% 0.08% 0.12% 0.40% 0.53% 0.00% 0.82% 0.82%
Augmented Payout Ratio
61.11% 25.15% 35.84% 12.40% 68.05% 48.78% 18.65% 41.33% 29.47% 22.85% 95.39%

Quarterly Metrics And Ratios for Central Garden & Pet

This table displays calculated financial ratios and metrics derived from Central Garden & Pet's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.78% 6.04% 1.09% -0.98% -2.63% -10.75% 3.45% -7.39% -3.56% 1.30% -5.95%
EBITDA Growth
9.11% -9.94% 33.28% 15.13% -4.46% -149.53% 49.87% -1.18% 13.48% 196.01% -22.24%
EBIT Growth
9.14% -27.78% 346.79% 18.62% -6.08% -601.63% 179.37% 0.85% 17.25% 81.90% -36.38%
NOPAT Growth
6.61% -27.36% 1,971.92% 20.51% -5.13% -445.91% 263.51% -0.27% 14.95% 80.25% -40.79%
Net Income Growth
10.58% 214.97% 106.41% 28.74% -3.68% -1,365.17% 2,401.06% 3.41% 18.56% 69.66% -51.63%
EPS Growth
10.58% 214.97% 106.41% 29.17% -4.80% -1,400.00% 2,000.00% 5.38% 27.73% 69.23% -47.62%
Operating Cash Flow Growth
71.15% 218.54% -10.24% 27.40% -11.87% 31.82% 1.36% -91.14% -7.21% -10.03% -2.02%
Free Cash Flow Firm Growth
138.94% 156.39% 142.10% 620.72% 29.98% -31.01% 81.06% 29.69% 41.70% -29.18% -74.21%
Invested Capital Growth
-1.80% -8.20% -5.04% -4.96% -3.81% -7.43% -9.14% -7.67% -6.68% -5.10% -2.25%
Revenue Q/Q Growth
12.57% -26.69% -15.41% 41.85% 10.69% -32.81% -1.95% 26.98% 15.28% -29.42% -8.97%
EBITDA Q/Q Growth
44.02% -79.08% 6.75% 257.99% 19.51% -110.84% 423.02% 136.05% 37.23% -90.82% 161.61%
EBIT Q/Q Growth
57.29% -93.79% 22.40% 891.77% 24.53% -133.18% 168.17% 258.01% 44.78% -105.12% 339.61%
NOPAT Q/Q Growth
56.26% -92.94% -10.21% 1,115.77% 23.02% -125.76% 194.35% 233.55% 41.79% -104.43% 382.88%
Net Income Q/Q Growth
71.64% -96.75% -79.15% 10,952.73% 28.42% -142.75% 141.22% 357.00% 47.22% -110.94% 165.72%
EPS Q/Q Growth
71.64% -96.75% -79.15% 9,200.00% 27.96% -143.70% 140.38% 366.67% 55.10% -110.53% 168.75%
Operating Cash Flow Q/Q Growth
1,061.32% -52.54% -145.29% 64.87% 1,266.92% -29.02% -133.89% 31.92% 666.49% -31.17% -138.43%
Free Cash Flow Firm Q/Q Growth
457.79% 46.53% -35.59% 54.21% -10.69% -22.22% 69.02% 10.45% -2.42% -61.12% -38.44%
Invested Capital Q/Q Growth
-8.86% -6.56% 6.94% 4.35% -7.75% -10.08% 4.97% 6.03% -6.76% -8.56% 8.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.08% 26.32% 28.19% 30.98% 31.82% 25.24% 29.81% 32.76% 34.55% 28.98% 30.87%
EBITDA Margin
14.27% 4.07% 5.14% 12.97% 14.01% -2.26% 7.45% 13.84% 16.48% 2.14% 6.16%
Operating Margin
12.00% 1.25% 1.33% 10.38% 11.64% -4.84% 4.26% 11.20% 14.06% -0.94% 2.68%
EBIT Margin
12.09% 1.02% 1.48% 10.36% 11.66% -5.76% 4.00% 11.29% 14.17% -1.03% 2.71%
Profit (Net Income) Margin
8.16% 0.36% 0.09% 6.96% 8.08% -5.14% 2.16% 7.77% 9.93% -1.54% 1.11%
Tax Burden Percent
75.58% -717.41% -187.75% 76.61% 75.96% 76.41% 76.47% 76.50% 74.92% 75.31% 76.65%
Interest Burden Percent
89.38% -4.93% -3.21% 87.70% 91.21% 116.80% 70.58% 90.05% 93.51% 198.64% 53.53%
Effective Tax Rate
24.42% 0.00% 0.00% 23.39% 24.04% 0.00% 23.53% 23.50% 25.08% 0.00% 23.35%
Return on Invested Capital (ROIC)
12.84% 1.30% 1.31% 10.75% 12.92% -5.27% 4.82% 11.78% 15.45% -1.07% 3.09%
ROIC Less NNEP Spread (ROIC-NNEP)
11.82% 0.84% 0.76% 9.86% 11.87% -7.38% 3.78% 10.92% 14.36% -2.74% 1.94%
Return on Net Nonoperating Assets (RNNOA)
7.68% 0.51% 0.52% 6.88% 5.64% -2.72% 1.77% 5.48% 4.82% -0.62% 0.63%
Return on Equity (ROE)
20.51% 1.80% 1.83% 17.62% 18.56% -7.98% 6.58% 17.26% 20.27% -1.69% 3.72%
Cash Return on Invested Capital (CROIC)
8.86% 15.87% 12.43% 12.55% 11.80% 14.63% 16.73% 14.78% 14.85% 15.04% 11.06%
Operating Return on Assets (OROA)
11.67% 1.02% 1.48% 9.95% 10.89% -5.32% 3.71% 9.93% 12.17% -0.90% 2.33%
Return on Assets (ROA)
7.89% 0.36% 0.09% 6.68% 7.54% -4.74% 2.00% 6.84% 8.53% -1.34% 0.96%
Return on Common Equity (ROCE)
20.49% 1.80% 1.83% 17.61% 18.54% -7.97% 6.58% 17.24% 20.24% -1.69% 3.72%
Return on Equity Simple (ROE_SIMPLE)
8.37% 0.00% 9.33% 9.90% 9.19% 0.00% 8.09% 8.11% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
93 6.56 5.89 72 88 -23 21 71 101 -4.48 13
NOPAT Margin
9.07% 0.87% 0.93% 7.95% 8.84% -3.39% 3.26% 8.57% 10.54% -0.66% 2.05%
Net Nonoperating Expense Percent (NNEP)
1.02% 0.46% 0.55% 0.89% 1.05% 2.12% 1.04% 0.86% 1.09% 1.67% 1.15%
Return On Investment Capital (ROIC_SIMPLE)
- - 0.22% - - - 0.79% 2.61% 3.64% -0.16% 0.46%
Cost of Revenue to Revenue
68.92% 73.68% 71.81% 69.02% 68.18% 74.76% 70.19% 67.24% 65.45% 71.02% 69.13%
SG&A Expenses to Revenue
19.08% 25.07% 26.86% 20.60% 20.19% 30.08% 25.55% 21.57% 20.49% 29.92% 28.20%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.08% 25.07% 26.86% 20.60% 20.19% 30.08% 25.55% 21.57% 20.49% 29.92% 28.20%
Earnings before Interest and Taxes (EBIT)
124 7.68 9.41 93 116 -39 26 94 136 -6.98 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
146 31 33 117 140 -15 49 115 158 15 38
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.41 1.63 1.86 1.90 1.63 1.59 1.69 1.53 1.41 1.32 1.29
Price to Tangible Book Value (P/TBV)
5.28 5.81 6.48 5.94 4.52 4.65 5.12 4.48 3.88 3.60 3.52
Price to Revenue (P/Rev)
0.62 0.72 0.81 0.87 0.79 0.77 0.80 0.75 0.72 0.67 0.66
Price to Earnings (P/E)
16.90 18.86 20.05 19.37 17.90 22.88 21.13 19.11 16.19 12.83 13.09
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.92% 5.30% 4.99% 5.16% 5.59% 4.37% 4.73% 5.23% 6.18% 7.79% 7.64%
Enterprise Value to Invested Capital (EV/IC)
1.26 1.43 1.54 1.57 1.45 1.46 1.51 1.37 1.32 1.27 1.23
Enterprise Value to Revenue (EV/Rev)
0.88 0.92 1.06 1.13 0.98 0.90 0.97 0.96 0.87 0.76 0.81
Enterprise Value to EBITDA (EV/EBITDA)
9.43 10.10 11.37 11.50 10.02 10.57 10.78 10.45 8.81 7.07 7.64
Enterprise Value to EBIT (EV/EBIT)
13.41 14.41 16.09 16.02 14.14 16.05 15.86 15.23 12.42 9.55 10.39
Enterprise Value to NOPAT (EV/NOPAT)
17.74 18.69 20.71 20.53 18.01 20.34 20.02 19.33 16.02 12.60 13.82
Enterprise Value to Operating Cash Flow (EV/OCF)
10.45 8.01 9.41 9.75 9.26 7.33 7.90 8.07 7.67 7.17 7.53
Enterprise Value to Free Cash Flow (EV/FCFF)
14.10 8.62 12.10 12.21 12.09 9.61 8.56 8.89 8.57 8.22 10.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.82 0.82 0.82 0.79 0.75 0.76 0.78 0.77 0.75 0.75 0.76
Long-Term Debt to Equity
0.82 0.82 0.82 0.79 0.75 0.76 0.78 0.77 0.75 0.75 0.76
Financial Leverage
0.65 0.60 0.69 0.70 0.48 0.37 0.47 0.50 0.34 0.23 0.33
Leverage Ratio
2.42 2.39 2.40 2.39 2.31 2.30 2.34 2.35 2.28 2.28 2.32
Compound Leverage Factor
2.16 -0.12 -0.08 2.10 2.11 2.69 1.65 2.11 2.13 4.54 1.24
Debt to Total Capital
45.08% 44.99% 45.02% 44.02% 42.71% 43.31% 43.92% 43.55% 42.82% 42.92% 43.07%
Short-Term Debt to Total Capital
0.01% 0.01% 0.02% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
45.07% 44.98% 45.00% 44.01% 42.70% 43.30% 43.92% 43.55% 42.82% 42.92% 43.07%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.06% 0.06% 0.03% 0.05% 0.08% 0.07% 0.03% 0.07% 0.08% 0.06% 0.02%
Common Equity to Total Capital
54.86% 54.95% 54.95% 55.93% 57.21% 56.62% 56.05% 56.38% 57.09% 57.02% 56.91%
Debt to EBITDA
3.88 3.93 3.83 3.65 3.72 4.35 4.10 4.13 3.87 3.53 3.65
Net Debt to EBITDA
2.75 2.27 2.68 2.68 1.89 1.54 1.92 2.28 1.51 0.87 1.39
Long-Term Debt to EBITDA
3.88 3.93 3.83 3.65 3.72 4.35 4.10 4.12 3.87 3.53 3.65
Debt to NOPAT
7.30 7.27 6.98 6.51 6.69 8.36 7.62 7.63 7.05 6.30 6.61
Net Debt to NOPAT
5.17 4.19 4.89 4.79 3.40 2.96 3.57 4.23 2.74 1.55 2.52
Long-Term Debt to NOPAT
7.30 7.27 6.98 6.51 6.69 8.36 7.62 7.63 7.05 6.30 6.61
Altman Z-Score
2.48 2.53 2.58 2.67 2.64 2.45 2.53 2.46 2.49 2.34 2.30
Noncontrolling Interest Sharing Ratio
0.11% 0.09% 0.05% 0.09% 0.12% 0.11% 0.05% 0.11% 0.14% 0.11% 0.04%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.51 3.73 3.47 3.33 3.66 3.66 3.47 3.31 3.56 3.67 3.42
Quick Ratio
1.66 1.79 1.44 1.58 2.07 2.10 1.87 1.83 2.20 2.24 1.88
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
135 198 127 196 175 136 230 254 248 97 59
Operating Cash Flow to CapEx
3,056.28% 1,174.66% -689.09% -262.20% 2,100.94% 2,022.99% -1,128.39% -439.62% 1,920.95% 1,685.98% -649.48%
Free Cash Flow to Firm to Interest Expense
9.27 15.03 8.89 13.65 11.90 9.65 15.92 17.53 17.29 6.72 4.09
Operating Cash Flow to Interest Expense
22.32 11.73 -4.87 -1.71 19.44 14.39 -4.76 -3.23 18.49 12.73 -4.84
Operating Cash Flow Less CapEx to Interest Expense
21.59 10.73 -5.58 -2.36 18.51 13.68 -5.18 -3.96 17.52 11.97 -5.58
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.97 0.99 1.00 0.96 0.93 0.92 0.93 0.88 0.86 0.87 0.86
Accounts Receivable Turnover
6.54 9.33 9.48 5.79 6.56 9.71 8.37 5.45 6.06 9.61 8.16
Inventory Turnover
2.65 2.66 2.40 2.48 2.80 2.83 2.56 2.53 2.86 2.88 2.54
Fixed Asset Turnover
8.35 8.39 8.44 8.45 8.45 8.30 8.48 8.35 8.31 8.43 8.47
Accounts Payable Turnover
10.55 11.62 11.63 10.09 11.86 11.19 10.42 8.79 10.70 9.53 8.64
Days Sales Outstanding (DSO)
55.79 39.13 38.52 63.06 55.64 37.58 43.63 66.92 60.26 38.00 44.72
Days Inventory Outstanding (DIO)
137.61 137.17 152.36 147.05 130.44 129.08 142.35 144.16 127.55 126.71 143.72
Days Payable Outstanding (DPO)
34.60 31.40 31.38 36.16 30.78 32.63 35.03 41.54 34.11 38.29 42.24
Cash Conversion Cycle (CCC)
158.79 144.89 159.50 173.95 155.30 134.03 150.96 169.53 153.69 126.42 146.21
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,288 2,138 2,287 2,386 2,201 1,979 2,078 2,203 2,054 1,878 2,031
Invested Capital Turnover
1.42 1.48 1.41 1.35 1.46 1.55 1.48 1.38 1.47 1.62 1.50
Increase / (Decrease) in Invested Capital
-42 -191 -121 -125 -87 -159 -209 -183 -147 -101 -47
Enterprise Value (EV)
2,884 3,056 3,531 3,749 3,202 2,895 3,127 3,016 2,708 2,384 2,493
Market Capitalization
2,042 2,369 2,697 2,874 2,595 2,471 2,569 2,354 2,242 2,089 2,038
Book Value per Share
$26.72 $27.04 $26.98 $28.09 $23.64 $23.07 $23.16 $23.53 $25.05 $25.18 $25.27
Tangible Book Value per Share
$7.15 $7.60 $7.74 $8.99 $8.52 $7.88 $7.65 $8.02 $9.12 $9.24 $9.30
Total Capital
2,635 2,641 2,642 2,701 2,785 2,748 2,710 2,734 2,782 2,777 2,768
Total Debt
1,188 1,188 1,190 1,189 1,190 1,190 1,190 1,191 1,191 1,192 1,192
Total Long-Term Debt
1,187 1,188 1,189 1,189 1,189 1,190 1,190 1,191 1,191 1,192 1,192
Net Debt
841 685 834 874 605 422 558 660 464 293 455
Capital Expenditures (CapEx)
11 13 10 9.35 14 10 6.10 11 14 11 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
899 747 865 979 805 603 712 846 710 539 655
Debt-free Net Working Capital (DFNWC)
1,246 1,249 1,220 1,294 1,389 1,372 1,344 1,378 1,438 1,437 1,392
Net Working Capital (NWC)
1,245 1,249 1,220 1,294 1,389 1,371 1,344 1,378 1,438 1,437 1,392
Net Nonoperating Expense (NNE)
9.28 3.84 5.32 8.92 7.59 12 7.22 6.59 5.82 5.96 5.81
Net Nonoperating Obligations (NNO)
841 685 834 874 605 422 558 660 464 293 455
Total Depreciation and Amortization (D&A)
22 23 23 23 23 23 23 21 22 22 21
Debt-free, Cash-free Net Working Capital to Revenue
27.51% 22.55% 26.07% 29.59% 24.52% 18.85% 22.09% 26.82% 22.77% 17.23% 21.18%
Debt-free Net Working Capital to Revenue
38.12% 37.74% 36.79% 39.13% 42.33% 42.86% 41.72% 43.66% 46.09% 45.94% 45.04%
Net Working Capital to Revenue
38.11% 37.74% 36.78% 39.12% 42.32% 42.85% 41.71% 43.65% 46.09% 45.94% 45.04%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.27 $0.03 $0.01 $0.94 $1.21 ($0.52) $0.22 $0.99 $1.53 ($0.16) $0.11
Adjusted Weighted Average Basic Shares Outstanding
65.45M 81.71M 65.29M 65.64M 65.85M 65.71M 64.55M 64.14M 61.98M 63.09M 61.41M
Adjusted Diluted Earnings per Share
$1.25 $0.03 $0.01 $0.93 $1.19 ($0.52) $0.21 $0.98 $1.52 ($0.16) $0.11
Adjusted Weighted Average Diluted Shares Outstanding
66.60M 83.32M 66.66M 66.83M 66.95M 66.86M 65.45M 64.88M 62.61M 63.82M 62.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.03 $0.00 $0.00 $0.00 ($0.52) $0.00 $0.00 $0.00 ($0.16) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
66.97M 67.14M 67.10M 67.40M 67.42M 65.59M 65.51M 63.41M 62.87M 62.33M 62.27M
Normalized Net Operating Profit after Tax (NOPAT)
93 6.56 5.89 72 88 -23 21 71 101 -4.48 13
Normalized NOPAT Margin
9.07% 0.87% 0.93% 7.95% 8.84% -3.39% 3.26% 8.57% 10.54% -0.66% 2.05%
Pre Tax Income Margin
10.80% -0.05% -0.05% 9.09% 10.63% -6.72% 2.83% 10.16% 13.25% -2.04% 1.45%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.51 0.58 0.66 6.49 7.89 -2.73 1.82 6.48 9.48 -0.49 1.15
NOPAT to Interest Expense
6.38 0.50 0.41 4.98 5.98 -1.61 1.48 4.92 7.05 -0.31 0.87
EBIT Less CapEx to Interest Expense
7.77 -0.41 -0.05 5.84 6.97 -3.44 1.39 5.75 8.52 -1.24 0.41
NOPAT Less CapEx to Interest Expense
5.65 -0.50 -0.30 4.33 5.06 -2.32 1.06 4.19 6.09 -1.07 0.13
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.66% 0.60% 0.61% 0.82% 1.09% 1.08% 0.96% 0.82% 0.73%
Augmented Payout Ratio
44.51% 29.47% 26.19% 22.71% 13.25% 22.85% 59.11% 89.23% 118.14% 95.39% 78.01%

Financials Breakdown Chart

Key Financial Trends

Here are key takeaways from Central Garden & Pet (CENTA) quarterly statements over the last four years, focusing on trends in cash flow, profitability, and balance sheet leverage. The data show liquidity strength and selective profitability in several quarters, but cash flow from operations has been volatile and generally negative in several periods, with investing and financing activities contributing to overall cash outflows in many quarters.

  • Strong liquidity cushion: Cash & equivalents were about $721 million in Q1 2026, with a large pool of total current assets supporting ongoing operations.
  • Healthy working capital: In Q1 2026, Total Current Assets (~$1.97B) vs. Total Current Liabilities (~$574M) yields a solid working capital buffer to fund operations and potential growth.
  • Profitability visible in multiple quarters: Net income attributable to common shareholders was meaningful in several quarters (e.g., about $95.0M in Q3 2025 and $63.6M in Q2 2025), indicating periods of strong earnings power.
  • Positive near-term cash flow in a standout quarter: Q3 2025 showed solid operating cash flow, with Net Cash From Continuing Operating Activities around $265.5M, signaling credible cash generation from core operations at least in that period.
  • Modest but stable capex activity: Capital expenditures (PPE purchases) trend is modest and largely in the single-digit to low tens of millions per quarter (for example, PPE purchases around $10–14M in recent quarters), suggesting ongoing investment without excessive acceleration.
  • Capital returns through buybacks: The company has engaged in share repurchases in several periods (e.g., notable buybacks in some quarters), indicating a use of cash to return capital to shareholders, though at a moderate pace.
  • Revenue levels remain sizeable and stable: Quarterly revenue generally sits in the mid-to-high hundreds of millions, with occasional spikes (e.g., around $960M in Q3 2025), suggesting a resilient base even amid quarterly fluctuations.
  • Debt level appears manageable within asset base: Long-term debt around $1.19–$1.21B and total liabilities near $2.0B–$2.1B against about $1.5–$1.6B in equity, indicating a reasonable leverage position for a balanced capital structure.
  • Operating cash flow frequently negative: Net cash from operating activities is negative in several quarters (e.g., Q1 2026: -$70.2M; Q4 2025: -$161.2M; Q2 2025: -$46.9M; Q1 2025: -$68.8M), highlighting ongoing cash burn from core operations despite occasional profitability.
  • Investing cash outflows are persistent: Net cash from investing activities is consistently negative due to acquisitions and capex (e.g., Q1 2026: -$67.8M; Q3 2025: -$13.8M; Q4 2025: -$10.8M), which suppresses free cash flow.
  • Financing cash flows often reduce cash: Net cash from financing activities typically negative (e.g., Q1 2026: around -$23.5M; Q3 2025: -$56.6M) due to debt repayments, share repurchases, and dividends, stressing liquidity if operating cash flow remains weak.
  • Working capital swings can pressure cash: Large movements in operating assets and liabilities (e.g., substantial net decreases in working capital in some quarters like -$151.4M in Q2 2025) can create volatility in cash generation independent of net income.

Overall, CENTA shows a solid balance sheet and occasional strong profitability, but investors should watch the ongoing cash-flow dynamics—particularly operating cash flow and the drag from investing and financing activities—when evaluating liquidity and the sustainability of capital returns.

05/08/26 01:11 PM ETAI Generated. May Contain Errors.

Central Garden & Pet Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Central Garden & Pet's financial year ends in September. Their financial year 2025 ended on September 27, 2025.

Central Garden & Pet's net income appears to be on an upward trend, with a most recent value of $163.96 million in 2025, rising from $33.02 million in 2015. The previous period was $109.31 million in 2024. See Central Garden & Pet's forecast for analyst expectations on what's next for the company.

Central Garden & Pet's total operating income in 2025 was $250.04 million, based on the following breakdown:
  • Total Gross Profit: $997.34 million
  • Total Operating Expenses: $747.29 million

Over the last 10 years, Central Garden & Pet's total revenue changed from $1.65 billion in 2015 to $3.13 billion in 2025, a change of 89.6%.

Central Garden & Pet's total liabilities were at $2.04 billion at the end of 2025, a 2.2% increase from 2024, and a 226.4% increase since 2015.

In the past 10 years, Central Garden & Pet's cash and equivalents has ranged from $32.40 million in 2017 to $882.49 million in 2025, and is currently $882.49 million as of their latest financial filing in 2025.

Over the last 10 years, Central Garden & Pet's book value per share changed from 10.12 in 2015 to 25.18 in 2025, a change of 148.8%.



Financial statements for NASDAQ:CENT last updated on 2/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners